CLINICAL DATA MANAGEMENT FEATURED ARTICLES
CLINICAL DATA MANAGEMENT WHITE PAPER & ARTICLES
-
Disconnected trial systems slow sites and patients. Centralizing logistics, payments, and data improves visibility, reduces admin work, and keeps enrollment on track for more patient‑focused studies.
-
Site payment models shape trial cost and execution. Compare visit‑based simplicity vs procedure‑level precision to see when flexibility and savings beat complexity — or when predictability wins.
-
Modern trials need financial workflows that match their complexity — align payments to procedures, centralize spend, and reduce delays to protect cash flow, support patients, and improve execution.
-
Life sciences leaders in 2026 need more than breakthrough science. Build operational clarity, scalable systems, and investor-ready visibility to support growth, funding, and execution.
-
Mastering the nuances between IRT and RTSM allows trial teams to move past confusing jargon and focus on the supply intelligence and randomization logic essential for study integrity.
CLINICAL DATA MANAGEMENT APPLICATIONS & STUDIES
-
Optimizing Wearable Adherence In A Phase 3 Oncology Trial5/15/2026
Long-term wearable monitoring only works if patients keep wearing the device, and in oncology trials, that’s easier said than done.
-
How A Complex Personalized Medicine Trial Migrated RTSM Software Without Disruption3/26/2026
Discover how a clinical-stage biotech automated its supply chain to protect patient enrollment and eliminate manual errors in a complex, multi-national genetic medicine trial.
-
How A Rare Disease Biotech Replaced Manual Processes With RTSM Software3/26/2026
Discover how a clinical-stage biotech automated its supply chain to protect patient enrollment and eliminate manual errors in a complex, multi-national genetic medicine trial.
-
Outgrowing Excel: Implementing RTSM Software In A Live Phase I Trial3/26/2026
Moving from manual spreadsheets to RTSM mid-study requires precision. Learn how clinical teams maintain trial momentum while executing protocol changes without delays.
-
Advancing Neuromuscular Research with Digital Endpoints1/20/2026
Explore cutting-edge digital measures that capture peak mobility and activity in real-world settings, offering meaningful insights into disease progression in neuromuscular disorders.
SOLUTIONS
- Site And Participant-Friendly Visit Scheduling Built For Global Trials
- Why Customers Are Switching To Medidata CTMS And eTMF
- Precision-Built IRT Software That Inspires Quick Action
- Accelerate Your Operations With Smarter Trial Management
- RTSM That's Ready For The Trials Ahead
- Improving The Patient Experience With Total Consent
- Medidata CTMS Leads The Industry
- The Hardest Trials Deserve The Easiest Solutions
- Elosity Overview
- Fast, Flexible Participant Payments In Clinical Trials
NEWS
-
Puraffinity Signs First Commercial Agreement For Full-Scale Deployment Of Its PFAS Removal Technology6/2/2025
The agreement was signed with Envytech Solutions, the leading expert in mobile water treatment in the Nordic region and a member of the Sortera Group, which operates across the Nordics and the UK.
-
How Lakes Connect To Groundwater Critical For Resilience To Climate Change7/9/2025
The study drew on data from 350 lakes across 18 European countries, collected between 2022 and 2024, to provide a comprehensive picture of how the continent’s lakes are coping with climate change.
-
Quantum Biopharma Announces Signing Of An Agreement With A Global Pharmaceutical Contract Research Organization To Prepare An IND (Investigational New Drug) Application Package For Lucid-21-302 (Lucid-MS), A First-In-Class Treatment For Multiple Sclerosis5/20/2025
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announces that it has signed an agreement with a global pharmaceutical contract research organization to prepare an IND (Investigational New Drug) application package for Lucid-21-302 (Lucid-MS) with the US FDA.
-
Ovarro Opens New Asia Pacific Headquarters8/27/2025
Water technology provider Ovarro has opened a new Asia Pacific headquarters and production facility in Selangor, Malaysia.
-
Agilitas Energy Expands Into Hydropower With Acquisition Of Two Projects In West Virginia And Maryland6/24/2025
Agilitas Energy, a leading developer and operator of renewable energy and energy storage systems, today announced the acquisition of two late-stage hydropower development projects from Advanced Hydro Solutions.